Impact of GLP-1 Drugs on Weight Loss Surgery Market
GLP-1 Drugs: A Potential Tailwind for Weight Loss Surgery Market Expansion
Carol Yepes/Moment via Getty Images The rising popularity of the GLP-1 class of anti-obesity medications developed by prominent pharmaceutical companies can potentially expand the weight loss surgery market in the long run, as per Bernstein’s recent research note. These treatments, marketed as Wegovy and Zepbound by Eli Lilly and Novo Nordisk respectively, have been linked ...












